Dr Inês Amado gained her doctorate in immunology. She is a former project manager of the Tech Transfer Consortium of Aviesan (French National Alliance for Life Sciences and Health) on Biomarkers & Companion diagnostics. Since September 2017 Inês has been Deputy Director of the Thematic Institute for Health Technologies at Inserm (French National Institute of Health and Medical Research) and Aviesan and she is the current project manager for the 2025 Genomic Medicine France Plan. Inês Amado – Médicine France Génomique 2025: Developing Genomic Medicine in France The French Plan for Genomic Medicine 2025 was commissioned in 2015 and implemented by Aviesan (the French National Alliance for Life Sciences and Health) in 2016. The aim is to foster the integration of genomic medicine into France’s healthcare system bringing together healthcare, research, training and industry. To meet these challenges, we proposed a transformative ten-year plan that will improve quality of life, drive scientific and technological innovation and promote economic growth. The French Plan is based on 14 operating measures. Genome sequencing will be performed by 12 ultra-high-throughput sequencing platforms covering the whole country, two of which have been launched in 2018. Of the €670M invested in the first five years, around €230M will come from industry. The French Plan includes the creation of an ambitious industrial sector that will constitute a new source of economic development and employment.

Watch Now